Alzamend Neuro, Inc. - ALZN

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q3 2026 · Compare: Q2 2026
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
Kingsbury Capital Investment Advisors LLC History Reduced 1,119,932 1,937 1.83% 1.35% 1 -209,168 -15.74% Q3 2026 Oct 20, 2026
GEODE CAPITAL MANAGEMENT, LLC History Reduced 26,264 45 0.0% 0.0% 2 -107 -0.41% Q3 2026 Nov 06, 2026
VANGUARD FIDUCIARY TRUST CO History No change 21,020 25 0.0% 0.0% 3 0 0.0% Q2 2026 Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLC History No change 7,556 9 0.0% 0.0% 4 0 0.0% Q2 2026 Aug 13, 2026
UBS Group AG History Added to 3,034 5 0.0% 0.0% 5 +682 29.0% Q3 2026 Nov 10, 2026
Tower Research Capital LLC (TRC) History No change 3,517 4 0.0% 0.0% 6 0 0.0% Q2 2026 Aug 11, 2026
Caitong International Asset Management Co., Ltd History Added to 4 0 — — — +1 33.33% Q3 2026 Oct 29, 2026
HARBOR INVESTMENT ADVISORY, LLC History No change 1 0 — — — 0 0.0% Q3 2026 Oct 13, 2026
IFG Advisory, LLC History No change 22 0 — — — 0 0.0% Q3 2026 Nov 06, 2026
SBI Securities Co., Ltd. History No change 22 0 — — — 0 0.0% Q3 2026 Oct 21, 2026
BlackRock, Inc. History No change 437 0 — — — 0 0.0% Q2 2026 Aug 07, 2026